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The Cys-loop ligand-gated ion channel family includes the GABA-, glycine-,
serotonin-, and nicotinergic acetylcholine receptors, which all play important
roles in the nervous signal transduction pathway. They are critical targets for
e.g. general anesthetics and alcohol, and all consist of five subunits organized
around a central pore. Here, we investigate the prokaryotic Gloeobacter viola-
ceus pentameric ligand-gated ion channel (GLIC) that is a homolog to the cys-
loop superfamily. GLIC has the advantage of having several X-ray structures
published, and we have previously used it for several different modeling
studies. To better understand the relation between gating and the pore proper-
ties if ligand-gated channels in general, we have substituted several amino res-
idues involved in the kinetics of open and closing of the channel, at different
pH. We have characterized these substitutions using an in vitro electrophysio-
logical functional assay (proton concentration response curves); expressing the
substituted channels in Xenopus laevis oocytes for two-electrode voltage clamp
experiments. We have also made single-channel recordings for investigating
the kinetics (open, closing, and flickering behavior) of the substitutions,
observed in silico. Our results indicate that the hydrophobicity of the pore is
critical to determine both the balance and kinetics of the opening/closing pro-
cess, and it is possible to alter the gating properties of the channel while still
keeping it functional. This is an important step in the process of developing
more effective anesthetics, with a better therapeutic window, but also to iden-
tify a possible molecular mechanism of how to reduce alcohol dependency.
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The prokaryotic Gloeobacter violaceus pentameric ligand-gated ion channel
(GLIC) is an important template for studies of Cys-loop receptors in the human
central nervous system. It is also a key model system to understand the transi-
tions and stabilization of different conformations of membrane proteins
through allosteric modulation - a ligand that opens the channel can either sta-
bilize the open state, or destabilize the closed one. Capturing these processes on
the molecular level will not only enable us to understand gating, but also make
it possible to predict functional responses rather than merely binding properties.
Over the last years, we have studied mutants of the GLIC channel that make it
more similar to the human Cys-loop receptors both experimentally and in sim-
ulations, and shown how this provides evidence for a dual allosteric modulation
mechanism with separate inhibitory and potentiating binding sites. Here, I will
present our new results on mutations in the central GLIC pore. By modifying
the hydrophobicity of one or several residues in the pore it is possible to alter
the pore hydration level, which in turn has paramount effects on the conforma-
tion - molecular simulations show that it is possible to stabilize the channel
either in the open or closed conformation independent of pH. By using
ensemble molecular dynamics simulations covering several tens of microsec-
onds, we show that it is possible to reversibly simulate transitions between con-
formations that are shown to actually conduct ions or block the current in
simulations. In vivo electrophysiology and single-channel recordings on the
mutants confirm this influence on the kinetics, and provide us with a way to
couple molecular-level dynamics and kinetics to the experimentally observed
equilibrium and transitions between conformations.
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Institut Pasteur, Paris, France.Pentameric ligand-gated ion channels (pLGIC) mediate fast chemical trans-
mission of nerve signals. The structure of GLIC, a bacterial proton-gated ho-
molog, has been established in its open and Locally Closed (LC)
conformations at acidic pH. Here we report a new crystal form where the
LC and open conformations coexist as discrete forms at acidic pH. These re-
sults, together with site-directed mutagenesis and physiological recordings,
shed new light on the allosteric transitions of pLGIC and their
pharmacology.Cardiac Muscle I
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The DK210 mutation in cardiac troponin T causes dilated cardiomyopathy
(DCM) in human by impairing cardiac systolic function through a decrease
in cardiac myofilament Ca2þ sensitivity. Knock-in mice on the BALB/c back-
ground exhibit progressive heart failure (HF), leading to premature death. In
this study, effects of Ca2þ sensitizer pimobendan on HF were examined using
this DCM model. Pimobendan was administered orally once daily at two
doses,10 (low dose) and 100 (high dose) mg/kg, at two different stages, 4
weeks old with ejection fraction (EF) of over 35% (compensated stage) and
6-9 weeks old with EF of less than 35% (end-stage). Pimobendan improved
life-expectancy at both stages, with a similar effect at low dose. High dose
pimobendan further improved it at compensated stage, but had a much less
effect than low dose at end-stage due to frequent sudden death. Pimobendan
prevented the increase in heart and lung weight in a dose-dependent manner
at compensated stage with the increase being almost completely blocked at
high dose, whereas it had no effects at end-stage at any dose. Only high
dose pimobendan improved HF symptoms such as dyspnea at end-stage
and prevented their development at compensated stage. These results suggest
that a high dose pimobendan might have beneficial effects to improve life ex-
pectancy at compensated stage by preventing the development of HF, but it
may conversely impair life-expectancy at end-stage HF by increasing the
risk of sudden death. On the other hand, a low dose pimobendan might
improve life-expectancy at end-stage HF, although it could not prevent HF
even at compensated stage. To clarify the mechanisms by which optimal
doses of pimobendan are different in compensated and end-stage HF, inves-
tigation of the effect of pimobendan on isolated cardiomyocytes is in
progress.
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After chronic myocardial infarction (CMI) the myocardium undergoes remod-
eling which is described initially as ‘hypertrophic’ followed by ‘de-compensa-
tion’. We have studied this phenomenon at the sarcomeric level to understand
how muscle mechanics, post-translational modifications, tissue morphology
and sarcomeric structures are affected in the remaining well-perfused tissue.
We use a rat model of left anterior descending (LAD) ligation to create pheno-
typic chronic myocardial infarction (CMI). A specialized temperature jump
(T-jump) approach assess changes to myocardial muscle function during phys-
iological shortening in saturating (32mM) and physiological (1mM) calcium
concentrations. During ‘compensation’ we observe higher power (45%)
compared to control. During ‘de-compensation’ we observe a 50% reduction
in peak power and 40% reduction in maximal unloaded shortening velocity
(Vmax). We exploit second harmonic generation (SHG) by two-photon excita-
tion microscopy (TPE) to assess collagen abundance and infiltration. Global
type I collagen abundance and infiltration increases 2-fold post-AMI but
does not change during disease progression. Phos-Tag SDS-PAGE is used to
assess Troponin I (TnI), Myosin Binding Protein C (MyBP-C) and Regulatory
Light Chain (RLC) phosphorylation. Electron microscopy is used to assess sar-
comeric organization and mitochondrial health and abundance. Sarcomeric
disorder becomes evident with disease progression as well as a global reduc-
tion in functional mitochondria. This study demonstrates that sarcomeric pro-
tein modification is an important modifier of cardiac muscle function during
344a Monday, February 17, 2014the evolution of disease, which mirrors the route of progression from ‘compen-
sated’ to ‘decompensated’ phenotypes that is part of the wider picture of heart
failure that encompasses changes to tissue structure and organelle morphology.
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This study focuses on a novel rescue mouse model generated to test the ef-
fect of regulatory light chain (RLC) phosphorylation on a diseased cardiac
phenotype. Pseudo-phosphorylation of the D166V (aspartic acid to valine)
mutation shown to be associated with a malignant phenotype of familial hy-
pertrophic cardiomyopathy (FHC) was examined. Transgenic (Tg) mice car-
rying the D166V mutation demonstrated severe functional and physiological
abnormalities and a significant decrease in endogenous RLC phosphorylation
compared with Tg-WT mice. These detrimental phenotypes were partially
rescued by either myosin light chain kinase-induced phosphorylation or by
using phosphomimic (S15D) D166V-RLC exchanged in porcine cardiac
muscle preparations. Transgenic rescue mice carrying the S15D-D166V mu-
tation have been generated and subjected to functional measurements.
Myofibrillar ATPase assays performed on Tg-S15D-D166V vs. Tg-D166V
and Tg-WT mice cardiac samples showed a pseudo-phosphorylation rescue
of an abnormal increase in calcium sensitivity (hallmark of FHC) caused by
the D166V mutation. A D166V-induced decrease in maximal ATPase activ-
ity was also reversed in Tg-S15D-D166V mice. Similarly, maximal force
and myofilament Ca2þ-sensitivity, that were largely compromised in Tg-
D166V skinned muscle fibers, were improved in the rescue mice and
brought to the level observed in Tg-WT. Histopathological analyses of heart
sections from age and gender matched mice from all groups demonstrated
an approximately four-fold decrease in the extent of fibrosis in the rescue
mice compared to Tg-D166V. The beneficial effects of S15D on the func-
tion of the D166V hearts were confirmed in vivo by invasive hemody-
namics. Results from this study emphasize the significance of RLC
phosphorylation in alleviating an FHC induced phenotype and could be
used in the development of therapeutic interventions to restore the normal
cardiac function.
Supported by NIH-HL108343 and HL071778.
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To understand the mechanism underlying the apical hypertrophic cardiomypa-
thy (AHCM)-causing mutation E99K in cardiac actin gene (ACTC), skinned
papillary muscle fibers from 2- and 5-mo old E99K transgenic mice were sub-
jected to sinusoidal length perturbations to study tension transients, and the
results were compared with those from age-matched non-transgenic (NTg)
mice.
We found that 1) at the standard activation, fibers from 5-mo E99K mice pro-
duced slightly lower tension, significantly lower stiffness, and significantly
lower rate constant of delayed tension (2pb), and lower magnitudes B and C
than those from 5-mo NTg mice; but these differences were not found in 2-
mo mice; 2) the basal stiffness at the relaxing state with or without BDM at
both 1 and 100Hz showed a trend of an increase in 2-mo and a trend of a
decrease in 5-mo E99K mice (without significance) compared to age-
matched NTg mice, and the tension and stiffness at rigor state were not signif-
icantly varied among different mouse groups; 3) pCa-tension study showed
increased pCa50 (Ca
2þ sensitivity) in 5-mo E99K mice, with a bigger change
in the 0 mM Pi solution (DpCa50=0.09, P=0.047) than in the 8 mM Pi solution
(DpCa50=0.04, P=0.091). A trend (not significant) of an increase in pCa50 was
also found in 2-mo E99K mice, and no difference with nH (cooperativity) in
both 2-mo and 5-mo mice.
We conclude that AHCM-causing ACTC E99K mutant resulted in alterations
in biomechanical parameters depending on age: there were no changes in the
observed parameters at 2 months, but more significant changes occurred at 5
months, which correlate well with the development of AHCM.1741-Pos Board B471
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Long-term exercise training is associated with characteristic structural and
functional changes of the myocardium, resulting in a condition called athlete’s
heart. Although exercise-induced left ventricular (LV) hypertrophy has been
investigated by several groups in animal models, a detailed hemodynamic char-
acterization is not available. We aimed at understanding the functional and
morphological changes in the heart following a three-month-long training
period in a rat model.
Athlete’s heart in rats was induced by swim training. The swimmer group was
exposed to 200 min/day exercise for 12 weeks. The control group swam only 5
min/day. Following the training period we assessed LV hypertrophy with echo-
cardiography and performed LV pressure-volume (P-V) analysis with a
pressure-conductance microcatheter to investigate in vivo cardiac function.
Finally, cardiac tissue histology was examined.
Echocardiography showed hypertrophy which was confirmed by LV wall-
thickness and heart weight data. Histology also verified LV hypertrophy.
We found unaltered heart rate, arterial pressure and LV end-diastolic volume
along with decreased LV end-systolic volume, thus increased stroke volume
and ejection fraction in the swimmers by invasive hemodynamic measure-
ments. The P-V-loop-derived sensitive, load-independent contractility in-
dexes, such as slope of end-systolic P-V relationship or preload recruitable
stroke work were significantly increased. The observed improvement of ven-
triculoarterial coupling along with increased LV stroke work and mechanical
efficiency reflect improved mechanoenergetics of athlete’s heart. Despite the
significant hypertrophy, we observed unaltered LV stiffness and improved
LV active relaxation.
According to our knowledge this is the first study that characterizes func-
tional changes and hemodynamic relations in exercise-induced cardiac hy-
pertrophy. Conceivably, changes in the active (myosin) and passive (titin)
sarcomeric elements underly the described functional myocardial
alterations.
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Alteration of the Ca2þ binding properties of the thin filament has been impli-
cated as the initiating factor for numerous cardiomyopathies. To directly test
if changes in the Ca2þ sensitivity of TnC can lead to altered heart function
and a diseased phenotype we utilized specifically engineered cardiac TnCs
with modified Ca sensitivities. The specifically designed TnCs allowed us
to test whether a direct increase (L48Q TnC) or decrease (D73N TnC) in
Ca2þ sensitivity of the myofilament would lead to a hypertrophic or dilated
cardiomyopathy, respectively. We used adeno-associated virus serotype 9
(AAV-9) containing either Control TnC, D73N TnC, or L48Q TnC to target
the heart. AAV-9 containing GFP or mCherry was used to verify that the
AAV-9 was able to infect the heart. The Ca2þ desensitized D73N TnC reca-
pitulated a dilated cardiomyopathy. The hearts presented with dilated ventri-
cles and had enlarged isolated cardiomyocytes that displayed decreased
contractility. In addition, nearly half of the D73N mice died suddenly by 8
weeks of age and demonstrated altered electrical properties via ECG - a com-
mon feature of human dilated cardiomyopathies. On the other hand, AAV-9
containing the Ca2þ sensitized L48Q TnC did not recapitulate the restrictive
or hypertrophic cardiomyopathy phenotypes commonly associated with
increased myofilament Ca2þ sensitivity. However, consistent with the
enhanced Ca2þ binding abilities of the L48Q TnC, the isolated L48Q TnC
cardiomyocytes showed increased contractility, which was recapitulated in
vivo via pressure-volume analysis. In summary, the results showed that an
alteration in the Ca2þ sensitivity of the myofilament can, but does not always,
lead to a diseased heart. In fact these engineered TnCs may be used as a
treatment strategy against various cardiac diseases such as myocardial
infarction.
